Tudor Investment Corp ET AL Purchases New Holdings in Envista Holdings Corporation $NVST

Tudor Investment Corp ET AL acquired a new position in shares of Envista Holdings Corporation (NYSE:NVST) in the third quarter, according to its most recent disclosure with the SEC. The firm acquired 81,686 shares of the company’s stock, valued at approximately $1,664,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Farther Finance Advisors LLC grew its position in Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the period. EverSource Wealth Advisors LLC raised its holdings in Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after purchasing an additional 1,909 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its holdings in Envista by 10,356.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock valued at $49,000 after purchasing an additional 2,382 shares in the last quarter.

Insider Buying and Selling at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares of the company’s stock, valued at approximately $971,460. This represents a 23.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.66% of the stock is currently owned by corporate insiders.

Envista Stock Up 0.0%

Shares of NYSE:NVST opened at $24.60 on Monday. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $4.03 billion, a P/E ratio of 87.86, a P/E/G ratio of 1.68 and a beta of 0.95. Envista Holdings Corporation has a 52-week low of $14.22 and a 52-week high of $30.42. The stock’s fifty day simple moving average is $26.56 and its 200-day simple moving average is $22.92.

Envista (NYSE:NVST) last announced its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The firm’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.24 earnings per share. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities research analysts forecast that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on NVST. Morgan Stanley set a $19.00 price target on Envista in a research note on Friday, February 6th. Piper Sandler reiterated a “neutral” rating and issued a $25.00 price objective (up from $21.00) on shares of Envista in a research note on Friday, February 6th. Leerink Partners set a $35.00 target price on shares of Envista and gave the stock an “outperform” rating in a research report on Friday, February 6th. UBS Group boosted their price target on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 3rd. Finally, Barclays raised their price objective on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a research note on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $27.75.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.